Literature DB >> 32955629

Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestation.

Romain Muller1, Antoine Briantais1, Benoit Faucher1, Patrick Borentain2, Cyril Nafati3, Valery Blasco3, Emilie Gregoire4, Emmanuelle Bernit1, Julie Seguier1, Benoit Meunier1, Jean-Robert Harlé1, Mikael Ebbo1, Nicolas Schleinitz5.   

Abstract

Acute severe hepatitis is a rare complication of adult-onset Still's disease (AOSD). This condition is poorly characterized. We performed a review of the medical literature to describe clinical, biological, pathological, and treatment characteristics from AOSD patients with acute severe hepatitis. Their characteristics were compared with AOSD patients without severe hepatitis. Twenty-one cases were collected including a new case reported here. Patients with severe hepatitis were mostly young adults with a median age of 28 years (range: 20 to 55 years). Overall, patients with severe hepatitis had less arthritis, macular rash, sore throat, lymphadenopathy, or splenomegaly than patients without severe hepatitis. Cytopenia was more frequent in case of severe hepatitis. Most patients were treated with steroids, and the use of biotherapies has increased over the last decade. Despite treatment, 49% of patients required liver transplantation and 24% died. Key Points • Acute severe hepatitis in adult-onset Still's disease (AOSD) is associated with liver transplantation and/or death in, respectively, 43% and 24% of cases. • Severe hepatitis is the inaugural manifestation of AOSD in half of cases. Diagnosis is difficult when extra-hepatic clinical manifestations are lacking. • The mechanism of hepatic necrosis in AOSD with severe hepatitis is unknown. Liver biopsy is not specific and should not delay treatment initiation.

Entities:  

Keywords:  AOSD; Hepatic transplantation; Hepatitis; Liver failure; Review

Mesh:

Year:  2020        PMID: 32955629     DOI: 10.1007/s10067-020-05383-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

Review 1.  Hepatotoxicity of methotrexate in rheumatic diseases.

Authors:  S Kevat; M Ahern; P Hall
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Fulminant hepatic failure in adult onset Still's disease.

Authors:  O Dino; G Provenzano; G Giannuoli; E Sciarrino; M Pouyet; L Pagliaro
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

Review 3.  Treatment of adult-onset Still's disease: a review.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Thomas Henry; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2014-12-22       Impact factor: 2.423

  3 in total
  3 in total

1.  The utility of liver transplantation to treat acute liver failure caused by adult-onset Still's disease: case reports.

Authors:  Yuri Ogasawara; Tomomi Kogiso; Yoshihito Kotera; Akiko Omori; Naoko Konda; Eri Sugano; Takaomi Sagawa; Makiko Taniai; Masayoshi Harigai; Hiroto Egawa; Masakazu Yamamoto; Katsutoshi Tokushige
Journal:  Clin J Gastroenterol       Date:  2021-04-01

Review 2.  Pediatric Acute Severe Hepatitis of Unknown Origin: What is New?

Authors:  Jing Li; Wei Hu; Ji-Yuan Zhang; Fu-Sheng Wang
Journal:  J Clin Transl Hepatol       Date:  2022-06-20

Review 3.  Strategy and Challenges of Paraclinical Examinations in Adult-Onset Still's Disease.

Authors:  Nicolas Poursac; Itsaso Odriozola; Marie-Elise Truchetet
Journal:  J Clin Med       Date:  2022-04-16       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.